Epidarex Capital Partners Limited (formerly Rock Spring Ventures) is an Edinburgh based venture capital firm investing in the life sciences and health technology sector in United States and United Kingdom. It prefers innovations from the educational sectors like universities. The company focuses on biotechnology, medical devices and pharmaceuticals, personalized medicine and diagnostics, and healthcare IT and services. As of 2019, the company has invested 23 times in 12 portfolio companies with three successful exits.
Timeline
Invested in
Patents
Funding Rounds Participated In
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
Theolytics
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $6.8 million (UK £5 million) Series A round....
FinSMEs
June 22, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
JD Alois
June 22, 2020
Crowdfund Insider
Click HERE to find out ⭐ The British Business Bank Commits £50 million to New Epidarex Capital III UK LP fund. | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.
References
Organization
Investor
Company
Venture capital firmCompany attributes
Pharmaceutical industry
Investment
Technology
Biology
Biotechnology
Bethesda, Maryland
Edinburgh
Tokyo
United KingdomPitchbook URL
Legal Name
Epidarex Capital Partners LLC
Full Address
137a George Street Edinburgh United Kingdom, EH2 4JY
7910 Woodmont Avenue Suite 1210 Bethesda, Maryland 20814
Email Address
info@epidarex.com
United States